S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
S&P 500   0.57 (+2.14%)
DOW   0.57 (+2.14%)
QQQ   270.31 (-0.43%)
AAPL   450.91 (+1.45%)
MSFT   208.25 (-1.99%)
FB   263.00 (-2.03%)
GOOGL   1,496.82 (-0.10%)
AMZN   3,148.16 (-0.61%)
NVDA   446.60 (-0.31%)
CGC   17.93 (+7.82%)
BABA   248.13 (-1.57%)
TSLA   1,418.57 (-2.35%)
GE   6.67 (+4.22%)
MU   49.15 (+0.82%)
AMD   82.24 (-3.08%)
T   30.20 (+0.60%)
F   7.09 (+3.35%)
ACB   10.22 (-0.49%)
GILD   68.51 (-1.21%)
NFLX   483.38 (-2.29%)
DIS   128.79 (-0.88%)
BAC   26.56 (+1.72%)
BA   179.41 (+5.52%)
Log in

NASDAQ:INFIInfinity Pharmaceuticals News Headlines

$1.07
+0.09 (+9.17 %)
(As of 08/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$0.98
Now: $1.07
$1.09
50-Day Range
$0.82
MA: $0.90
$1.08
52-Week Range
$0.60
Now: $1.07
$1.68
Volume926,577 shs
Average Volume366,065 shs
Market Capitalization$62.99 million
P/E RatioN/A
Dividend YieldN/A
Beta1.75

Headlines

Infinity Pharmaceuticals (NASDAQ INFI) News Headlines

Source:
DateHeadline
Infinity Pharmaceuticals (NASDAQ:INFI) Trading 9.2% Higher Infinity Pharmaceuticals (NASDAQ:INFI) Trading 9.2% Higher
americanbankingnews.com - August 10 at 8:07 PM
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Expected to Post Quarterly Sales of $220,000.00Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Expected to Post Quarterly Sales of $220,000.00
americanbankingnews.com - August 10 at 4:15 AM
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Expected to Post Earnings of -$0.15 Per ShareInfinity Pharmaceuticals Inc. (NASDAQ:INFI) Expected to Post Earnings of -$0.15 Per Share
americanbankingnews.com - August 8 at 4:20 PM
Pancreatic Cancer Market 2020-2026 Analysis Examined in New Market Research Report with Focusing Key PlayersPancreatic Cancer Market 2020-2026 Analysis Examined in New Market Research Report with Focusing Key Players
www.marketwatch.com - August 3 at 1:39 PM
Infinity Pharmaceuticals (NASDAQ:INFI) Releases Quarterly  Earnings Results, Beats Estimates By $0.04 EPSInfinity Pharmaceuticals (NASDAQ:INFI) Releases Quarterly Earnings Results, Beats Estimates By $0.04 EPS
www.americanbankingnews.com - August 1 at 7:56 PM
Short Interest in Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Rises By 34.9%Short Interest in Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Rises By 34.9%
www.americanbankingnews.com - August 1 at 12:47 AM
Infinity Pharmaceuticals (NASDAQ:INFI) Trading Up 6.3% Following Better-Than-Expected EarningsInfinity Pharmaceuticals (NASDAQ:INFI) Trading Up 6.3% Following Better-Than-Expected Earnings
www.americanbankingnews.com - July 31 at 6:16 PM
Infinity Pharmaceuticals (INFI) "Buy" Rating Reaffirmed at OppenheimerInfinity Pharmaceuticals' (INFI) "Buy" Rating Reaffirmed at Oppenheimer
www.americanbankingnews.com - July 31 at 1:05 PM
Infinity Pharmaceuticals (INFI) CEO Adelene Perkins on Q2 2020 Results - Earnings Call TranscriptInfinity Pharmaceuticals' (INFI) CEO Adelene Perkins on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - July 31 at 7:56 AM
Infinity Pharmaceuticals Provides Company Update and Second Quarter 2020 Financial ResultsInfinity Pharmaceuticals Provides Company Update and Second Quarter 2020 Financial Results
finance.yahoo.com - July 30 at 8:13 PM
Infinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue EstimatesInfinity Pharmaceuticals (INFI) Reports Q2 Loss, Tops Revenue Estimates
finance.yahoo.com - July 30 at 8:13 PM
Infinity Pharmaceuticals (INFI) Set to Announce Quarterly Earnings on ThursdayInfinity Pharmaceuticals (INFI) Set to Announce Quarterly Earnings on Thursday
www.americanbankingnews.com - July 24 at 8:51 AM
Infinity Announces the Date of Its Second Quarter Financial Results Conference Call and WebcastInfinity Announces the Date of Its Second Quarter Financial Results Conference Call and Webcast
finance.yahoo.com - July 23 at 10:18 AM
Zacks: Brokerages Expect Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Will Announce Quarterly Sales of $200,000.00Zacks: Brokerages Expect Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Will Announce Quarterly Sales of $200,000.00
www.americanbankingnews.com - July 18 at 2:10 AM
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Expected to Post Earnings of -$0.20 Per ShareInfinity Pharmaceuticals Inc. (NASDAQ:INFI) Expected to Post Earnings of -$0.20 Per Share
www.americanbankingnews.com - July 16 at 2:36 PM
Apoptosis Market 2020 Size, Industry Share, Top Key Players, Industry Analysis and Forecast by 2025Apoptosis Market 2020 Size, Industry Share, Top Key Players, Industry Analysis and Forecast by 2025
www.marketwatch.com - June 25 at 9:50 AM
BRIEF-Infinity - Stockholders Approved To Increase Number Of Authorized Shares Of Common Stock To 200 Mln SharesBRIEF-Infinity - Stockholders Approved To Increase Number Of Authorized Shares Of Common Stock To 200 Mln Shares
www.reuters.com - June 19 at 8:27 AM
Apoptosis Market Share, Size Analysis with Industry Segment 2020 Manufacturers Data by Types and Applications Forecast to 2026Apoptosis Market Share, Size Analysis with Industry Segment 2020 Manufacturers Data by Types and Applications Forecast to 2026
www.marketwatch.com - June 18 at 9:52 AM
Infinity (INFI) Up 4% Since Last Earnings Report: Can It Continue?Infinity (INFI) Up 4% Since Last Earnings Report: Can It Continue?
finance.yahoo.com - June 10 at 2:50 PM
Infinity (INFI) Looks Good: Stock Adds 5.3% in SessionInfinity (INFI) Looks Good: Stock Adds 5.3% in Session
finance.yahoo.com - June 10 at 9:49 AM
Infinity Pharmaceuticals to Host a Virtual-Only 2020 Annual Meeting of StockholdersInfinity Pharmaceuticals to Host a Virtual-Only 2020 Annual Meeting of Stockholders
finance.yahoo.com - June 4 at 11:03 AM
Infinity (INFI) Q1 Earnings Lag Estimates, IPI-549 in FocusInfinity (INFI) Q1 Earnings Lag Estimates, IPI-549 in Focus
finance.yahoo.com - May 12 at 5:20 PM
Edited Transcript of INFI earnings conference call or presentation 11-May-20 8:30pm GMTEdited Transcript of INFI earnings conference call or presentation 11-May-20 8:30pm GMT
finance.yahoo.com - May 12 at 5:20 PM
Infinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2020 Results - Earnings Call TranscriptInfinity Pharmaceuticals, Inc. (INFI) CEO Adelene Perkins on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 2:58 AM
BRIEF-Infinity Pharmaceuticals Reports Q1 Loss Per Share Of $0.19BRIEF-Infinity Pharmaceuticals Reports Q1 Loss Per Share Of $0.19
www.reuters.com - May 11 at 9:58 PM
Infinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue EstimatesInfinity Pharmaceuticals (INFI) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 11 at 4:57 PM
Infinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial ResultsInfinity Pharmaceuticals Provides Company Update and First Quarter 2020 Financial Results
www.businesswire.com - May 11 at 8:01 AM
Diffuse Large B-cell Lymphoma Market Therapeutic Survey Reviews, Analysis 2020 | Amgen, Inc., AstraZeneca plc, Astellas Pharma IncDiffuse Large B-cell Lymphoma Market Therapeutic Survey Reviews, Analysis 2020 | Amgen, Inc., AstraZeneca plc, Astellas Pharma Inc
www.marketwatch.com - May 1 at 4:51 AM
Will Infinity Pharmaceuticals (INFI) Report Negative Q1 Earnings? What You Should KnowWill Infinity Pharmaceuticals (INFI) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - April 28 at 4:48 PM
Pancreatic Cancer Market 2020 Global, Size, Trends, Demand and Share Analysis to 2025Pancreatic Cancer Market 2020 Global, Size, Trends, Demand and Share Analysis to 2025
www.marketwatch.com - April 24 at 9:17 AM
If You Had Bought Infinity Pharmaceuticals (NASDAQ:INFI) Stock Five Years Ago, You'd Be Sitting On A 93% Loss, TodayIf You Had Bought Infinity Pharmaceuticals (NASDAQ:INFI) Stock Five Years Ago, You'd Be Sitting On A 93% Loss, Today
finance.yahoo.com - April 20 at 8:44 AM
Infinity (INFI) Upgraded to Buy: What Does It Mean for the Stock?Infinity (INFI) Upgraded to Buy: What Does It Mean for the Stock?
finance.yahoo.com - April 10 at 2:23 PM
Infinity Pharmaceuticals Provides Update in Response to COVID-19 PandemicInfinity Pharmaceuticals Provides Update in Response to COVID-19 Pandemic
finance.yahoo.com - April 7 at 4:47 PM
Pancreatic Cancer Market 2020 Size, Share, Current trends, Opportunities, Competitive Analysis and Forecast to 2025Pancreatic Cancer Market 2020 Size, Share, Current trends, Opportunities, Competitive Analysis and Forecast to 2025
www.marketwatch.com - April 6 at 9:10 PM
Infinity (INFI) Down 28.2% Since Last Earnings Report: Can It Rebound?Infinity (INFI) Down 28.2% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - April 2 at 4:24 PM
Why Infinity Pharmaceuticals Stock Is Trading Higher TodayWhy Infinity Pharmaceutical's Stock Is Trading Higher Today
www.benzinga.com - March 25 at 1:37 PM
Infinity Receives Fast Track Designation for IPI-549 in Combination with the Checkpoint Inhibitor Opdivo for the Treatment of Advanced Urothelial CancerInfinity Receives Fast Track Designation for IPI-549 in Combination with the Checkpoint Inhibitor Opdivo for the Treatment of Advanced Urothelial Cancer
finance.yahoo.com - March 25 at 8:36 AM
Rebag Extends Infinity Program Increasing Endless Access to Luxury HandbagsRebag Extends Infinity Program Increasing Endless Access to Luxury Handbags
www.prnewswire.com - March 20 at 12:03 PM
Pancreatic Cancer Market 2020 Demand, Current Trends, Growth Analysis, Competitor Analysis, Future Forecast 2025Pancreatic Cancer Market 2020 Demand, Current Trends, Growth Analysis, Competitor Analysis, Future Forecast 2025
www.marketwatch.com - March 19 at 4:00 PM
Arcus Biosciences Anti-TIGIT Candidate Puts Company In The Shop WindowArcus Biosciences Anti-TIGIT Candidate Puts Company In The Shop Window
seekingalpha.com - March 16 at 10:33 PM
Edited Transcript of INFI earnings conference call or presentation 3-Mar-20 9:30pm GMTEdited Transcript of INFI earnings conference call or presentation 3-Mar-20 9:30pm GMT
finance.yahoo.com - March 15 at 8:30 AM
Infinity (INFI) Q4 Loss Wider Than Expected, IPI-549 in FocusInfinity (INFI) Q4 Loss Wider Than Expected, IPI-549 in Focus
finance.yahoo.com - March 4 at 6:47 PM
Infinity Pharmaceuticals EPS in-line, beats on revenueInfinity Pharmaceuticals EPS in-line, beats on revenue
seekingalpha.com - March 3 at 5:53 PM
BRIEF-Infinity Pharmaceuticals Expects Net Loss For 2020 Between $40 Mln And $50 MlnBRIEF-Infinity Pharmaceuticals Expects Net Loss For 2020 Between $40 Mln And $50 Mln
www.reuters.com - March 3 at 5:53 PM
Infinity Pharmaceuticals Reports Full Year 2019 Financial Results and Provides Company UpdateInfinity Pharmaceuticals Reports Full Year 2019 Financial Results and Provides Company Update
finance.yahoo.com - March 3 at 5:53 PM
Infinity Announces the Date of Its Fourth Quarter and Full Year 2019 Financial Results Conference Call and WebcastInfinity Announces the Date of Its Fourth Quarter and Full Year 2019 Financial Results Conference Call and Webcast
finance.yahoo.com - February 25 at 12:21 PM
Infinity Pharmaceuticals, Inc. Common Stock (INFI) Insider ActivityInfinity Pharmaceuticals, Inc. Common Stock (INFI) Insider Activity
www.nasdaq.com - February 14 at 12:43 AM
Infinity Pharmaceuticals: Cash Position Boosted, Multiple Readouts Over The Next YearInfinity Pharmaceuticals: Cash Position Boosted, Multiple Readouts Over The Next Year
seekingalpha.com - February 10 at 11:00 PM
What Kind Of Share Price Volatility Should You Expect For Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)?What Kind Of Share Price Volatility Should You Expect For Infinity Pharmaceuticals, Inc. (NASDAQ:INFI)?
finance.yahoo.com - January 23 at 5:16 PM
Infinity Pharmaceuticals (INFI) Presents At 38th Annual J.P. Morgan Healthcare Conference - SlideshowInfinity Pharmaceuticals (INFI) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 17 at 4:03 PM
This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.